title: Homodimeric forms of bombesin act as potent antagonists of bombesin on Swiss 3T3 cells.
abstract: Two Lys3-bombesin dimers were prepared by crosslinking epsilon-amino groups Lys3-bombesin with noncleavable (glutaraldehyde) and cleavable [dimethyl-3,3'-dithiobispropionimidate (DTBP)] crosslinkers. The dimers were purified by HPLC ion-exchange chromatography and were shown to have retained immunoreactivity with an anti-bombesin monoclonal antibody directed against the C-terminal binding region of bombesin. The glutaraldehyde cross-linked bombesin dimer specifically inhibited binding of 125I-GRP to its receptor on Swiss 3T3 cells. Bombesin, at 0.6-60 nM induced mitogenesis in quiescent Swiss 3T3 cells, whereas, incubation of cells with the glutaraldehyde bombesin dimer at concentrations up to 124 nM did not. In competition assays, the bombesin dimer exhibited a dose dependent inhibition of bombesin-induced mitogenic activity and intracellular Ca++ mobilization. The bombesin dimer was 100 to 1000-fold more potent than D-Phe12Leu14-bombesin and D-Phe12bombesin, respectively, in inhibiting bombesin-induced mitogenesis on quiescent Swiss 3T3 cells. Similarly, the DTBP-bombesin dimer was not mitogenic to Swiss 3T3 cells, however, cleavage of the disulfide crosslinker with DTT of cell bound DTBP dimer restored mitogenic activity. Finally, the glutaraldehyde bombesin dimer also inhibited growth of bombesin receptor positive H345 SCLC cells in vitro. These findings suggest that the dimeric forms of bombesin are potent antagonists of bombesin.
authors.affiliation: Bristol-Myers Squibb Co., Department of Immunology, Wallingford, CT 06492.
authors.forename: S L
authors.initials: SL
authors.lastname: Gawlak
authors.forename: P A
authors.initials: PA
authors.lastname: Kiener
authors.forename: G R
authors.initials: GR
authors.lastname: Braslawsky
authors.forename: R S
authors.initials: RS
authors.lastname: Greenfield
mesh_terms: D016475:3T3 Cells; D000818:Animals; D001667:Binding, Competitive; D001839:Bombesin / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D003432:Cross-Linking Reagents; D004247:DNA / Q000096:biosynthesis; D051379:Mice; D011487:Protein Conformation; D018004:Receptors, Bombesin; D017981:Receptors, Neurotransmitter / Q000378:metabolism
chemical_list: D003432:Cross-Linking Reagents; D018004:Receptors, Bombesin; D017981:Receptors, Neurotransmitter; D004247:DNA; D001839:Bombesin; D002118:Calcium